Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling – HFpEF-DIVA

Ebba Brakenhielm (ENDOTHELIUM, VALVULOPATHIES ET INSUFFISANCE CARDIAQUE)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

EnVI ENDOTHELIUM, VALVULOPATHIES ET INSUFFISANCE CARDIAQUE
KU Leuven
Hybrigenics SAS

Help of the ANR 392,284 euros
Beginning and duration of the scientific project: May 2024 - 36 Months

• List of selected projects
• Permanent link to this summary on the ANR website (ANR-23-R4HC-0010)
• See the publications in the HAL-ANR portal